INZY
Price
$1.36
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
87.37M
61 days until earnings call
NAUT
Price
$1.93
Change
+$0.03 (+1.58%)
Updated
Jan 17 closing price
Capitalization
242.34M
33 days until earnings call
Ad is loading...

INZY vs NAUT

Header iconINZY vs NAUT Comparison
Open Charts INZY vs NAUTBanner chart's image
Inozyme Pharma
Price$1.36
Change-$0.00 (-0.00%)
Volume$1.36M
Capitalization87.37M
Nautilus Biotechnolgy
Price$1.93
Change+$0.03 (+1.58%)
Volume$77.54K
Capitalization242.34M
INZY vs NAUT Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. NAUT commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Hold and NAUT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (INZY: $1.36 vs. NAUT: $1.93)
Brand notoriety: INZY and NAUT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 170% vs. NAUT: 53%
Market capitalization -- INZY: $87.37M vs. NAUT: $242.34M
INZY [@Biotechnology] is valued at $87.37M. NAUT’s [@Biotechnology] market capitalization is $242.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 1 FA rating(s) are green whileNAUT’s FA Score has 1 green FA rating(s).

  • INZY’s FA Score: 1 green, 4 red.
  • NAUT’s FA Score: 1 green, 4 red.
According to our system of comparison, both INZY and NAUT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while NAUT’s TA Score has 4 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 4 bearish.
  • NAUT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both INZY and NAUT are a good buy in the short-term.

Price Growth

INZY (@Biotechnology) experienced а -31.83% price change this week, while NAUT (@Biotechnology) price change was +9.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

INZY is expected to report earnings on May 13, 2025.

NAUT is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAUT($242M) has a higher market cap than INZY($87.4M). NAUT YTD gains are higher at: 14.881 vs. INZY (-50.903). NAUT has higher annual earnings (EBITDA): -75.11M vs. INZY (-90.3M). NAUT has more cash in the bank: 141M vs. INZY (132M). NAUT has less debt than INZY: NAUT (31.6M) vs INZY (46.8M). INZY (0) and NAUT (0) have equivalent revenues.
INZYNAUTINZY / NAUT
Capitalization87.4M242M36%
EBITDA-90.3M-75.11M120%
Gain YTD-50.90314.881-342%
P/E RatioN/AN/A-
Revenue00-
Total Cash132M141M94%
Total Debt46.8M31.6M148%
FUNDAMENTALS RATINGS
NAUT: Fundamental Ratings
NAUT
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INZYNAUT
RSI
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
89%
Bearish Trend 5 days ago
83%
Momentum
ODDS (%)
Bearish Trend 5 days ago
88%
Bullish Trend 5 days ago
82%
MACD
ODDS (%)
Bearish Trend 5 days ago
88%
Bullish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
79%
Advances
ODDS (%)
Bullish Trend 16 days ago
86%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 20 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
81%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
77%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with IGMS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
N/A
IGMS - INZY
52%
Loosely correlated
-3.28%
BEAM - INZY
50%
Loosely correlated
+0.17%
FULC - INZY
49%
Loosely correlated
-0.50%
THRD - INZY
47%
Loosely correlated
+1.94%
NTLA - INZY
47%
Loosely correlated
+0.85%
More

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with PLRX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
+1.58%
PLRX - NAUT
45%
Loosely correlated
-3.36%
DNLI - NAUT
44%
Loosely correlated
+1.20%
AURA - NAUT
43%
Loosely correlated
+1.30%
PRTA - NAUT
42%
Loosely correlated
+4.48%
INZY - NAUT
42%
Loosely correlated
N/A
More